| Year |
Citation |
Score |
| 2020 |
Viscardi RM, Terrin ML, Magder LS, Davis NL, Dulkerian SJ, Waites KB, Namasivayam A, Kaufman DA, Donohue P, Tuttle DJ, Weitkamp JH, Hassan HE, Eddington ND. Randomised trial of azithromycin to eradicate in preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition. PMID 32170033 DOI: 10.1136/Archdischild-2019-318122 |
0.579 |
|
| 2015 |
Merchan LM, Hassan HE, Terrin ML, Waites KB, Kaufman DA, Ambalavanan N, Donohue P, Dulkerian SJ, Schelonka R, Magder LS, Shukla S, Eddington ND, Viscardi RM. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. Antimicrobial Agents and Chemotherapy. 59: 570-8. PMID 25385115 DOI: 10.1128/Aac.03951-14 |
0.648 |
|
| 2014 |
Metcalf MD, Rosicky AD, Hassan HE, Eddington ND, Coop A, Cunningham CW, Mercer SL. Opioids and efflux transporters. Part 4: influence of N-substitution on P-glycoprotein substrate activity of noroxymorphone analogues. Bioorganic & Medicinal Chemistry Letters. 24: 3592-5. PMID 24915880 DOI: 10.1016/J.Bmcl.2014.05.033 |
0.657 |
|
| 2013 |
Hassan HE, Myers AL, Lee IJ, Mason CW, Wang D, Sinz MW, Wang H, Eddington ND. Induction of xenobiotic receptors, transporters, and drug metabolizing enzymes by oxycodone. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 1060-9. PMID 23439660 DOI: 10.1124/Dmd.112.050401 |
0.623 |
|
| 2013 |
Viscardi RM, Othman AA, Hassan HE, Eddington ND, Abebe E, Terrin ML, Kaufman DA, Waites KB. Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose. Antimicrobial Agents and Chemotherapy. 57: 2127-33. PMID 23439637 DOI: 10.1128/Aac.02183-12 |
0.651 |
|
| 2011 |
Upreti VV, Moon KH, Yu LR, Lee IJ, Eddington ND, Ye X, Veenstra TD, Song BJ. Increased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver. Proteomics. 11: 202-11. PMID 21204248 DOI: 10.1002/Pmic.201000203 |
0.653 |
|
| 2011 |
Hassan HE, Othman AA, Eddington ND, Duffy L, Xiao L, Waites KB, Kaufman DA, Fairchild KD, Terrin ML, Viscardi RM. Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia. Journal of Clinical Pharmacology. 51: 1264-75. PMID 21098694 DOI: 10.1177/0091270010382021 |
0.632 |
|
| 2010 |
Li L, Hassan HE, Tolson AH, Ferguson SS, Eddington ND, Wang H. Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells. The Journal of Pharmacology and Experimental Therapeutics. 335: 562-71. PMID 20829393 DOI: 10.1124/Jpet.110.173187 |
0.637 |
|
| 2010 |
Myers AL, Hassan HE, Lee IJ, Eddington ND. Repeated administration of oxycodone modifies the gene expression of several drug metabolising enzymes in the hepatic tissue of male Sprague-Dawley rats, including glutathione S-transferase A-5 (rGSTA5) and CYP3A2. The Journal of Pharmacy and Pharmacology. 62: 189-96. PMID 20487198 DOI: 10.1211/Jpp.62.02.0006 |
0.643 |
|
| 2010 |
Song BJ, Moon KH, Upreti VV, Eddington ND, Lee IJ. Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage. Current Pharmaceutical Biotechnology. 11: 434-43. PMID 20420575 DOI: 10.2174/138920110791591436 |
0.643 |
|
| 2010 |
Mason CW, Hassan HE, Kim KP, Cao J, Eddington ND, Newman AH, Voulalas PJ. Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse. The Journal of Pharmacology and Experimental Therapeutics. 333: 854-64. PMID 20228156 DOI: 10.1124/Jpet.109.165084 |
0.676 |
|
| 2010 |
Fisher SJ, Swaan PW, Eddington ND. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo. The Journal of Pharmacology and Experimental Therapeutics. 332: 326-33. PMID 19820208 DOI: 10.1124/Jpet.109.158642 |
0.339 |
|
| 2010 |
Hassan HE, Myers AL, Lee IJ, Chen H, Coop A, Eddington ND. Regulation of gene expression in brain tissues of rats repeatedly treated by the highly abused opioid agonist, oxycodone: microarray profiling and gene mapping analysis. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 38: 157-67. PMID 19786507 DOI: 10.1124/Dmd.109.029199 |
0.665 |
|
| 2009 |
Coles LD, Lee IJ, Voulalas PJ, Eddington ND. Estradiol and progesterone-mediated regulation of P-gp in P-gp overexpressing cells (NCI-ADR-RES) and placental cells (JAR). Molecular Pharmaceutics. 6: 1816-25. PMID 19813763 DOI: 10.1021/Mp900077Q |
0.675 |
|
| 2009 |
Tolson AH, Li H, Eddington ND, Wang H. Methadone induces the expression of hepatic drug-metabolizing enzymes through the activation of pregnane X receptor and constitutive androstane receptor. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 1887-94. PMID 19520773 DOI: 10.1124/Dmd.109.027854 |
0.343 |
|
| 2009 |
Hassan HE, Mercer SL, Cunningham CW, Coop A, Eddington ND. Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions. International Journal of Pharmaceutics. 375: 48-54. PMID 19481690 DOI: 10.1016/J.Ijpharm.2009.03.037 |
0.632 |
|
| 2009 |
Teksin ZS, Lee IJ, Nemieboka NN, Othman AA, Upreti VV, Hassan HE, Syed SS, Prisinzano TE, Eddington ND. Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 72: 471-7. PMID 19462483 DOI: 10.1016/J.Ejpb.2009.01.002 |
0.795 |
|
| 2009 |
Upreti VV, Eddington ND, Moon KH, Song BJ, Lee IJ. Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine ("ecstasy"). Toxicology Letters. 188: 167-72. PMID 19446252 DOI: 10.1016/J.Toxlet.2009.03.023 |
0.658 |
|
| 2009 |
Hassan HE, Myers AL, Coop A, Eddington ND. Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluation. Journal of Pharmaceutical Sciences. 98: 4928-40. PMID 19370547 DOI: 10.1002/Jps.21770 |
0.67 |
|
| 2009 |
Coles LD, Lee IJ, Hassan HE, Eddington ND. Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. Journal of Pharmaceutical Sciences. 98: 2832-46. PMID 19116954 DOI: 10.1002/Jps.21644 |
0.765 |
|
| 2008 |
Moon KH, Upreti VV, Yu LR, Lee IJ, Ye X, Eddington ND, Veenstra TD, Song BJ. Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics. 8: 3906-18. PMID 18780394 DOI: 10.1002/Pmic.200800215 |
0.645 |
|
| 2008 |
Myers AL, Upreti VV, Khurana M, Eddington ND. Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin. Journal of Clinical Pharmacology. 48: 1158-70. PMID 18757783 DOI: 10.1177/0091270008323751 |
0.67 |
|
| 2008 |
Mercer SL, Cunningham CW, Eddington ND, Coop A. Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogs. Bioorganic & Medicinal Chemistry Letters. 18: 3638-40. PMID 18499452 DOI: 10.1016/J.Bmcl.2008.04.046 |
0.341 |
|
| 2008 |
Cunningham CW, Mercer SL, Hassan HE, Traynor JR, Eddington ND, Coop A. Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs. Journal of Medicinal Chemistry. 51: 2316-20. PMID 18311899 DOI: 10.1021/Jm701457J |
0.646 |
|
| 2008 |
Song KH, Fasano A, Eddington ND. Enhanced nasal absorption of hydrophilic markers after dosing with AT1002, a tight junction modulator. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 69: 231-7. PMID 18039562 DOI: 10.1016/J.Ejpb.2007.10.011 |
0.411 |
|
| 2008 |
Fisher SJ, Lee IJ, Swaan PW, Eddington ND. Evaluation of the effect of ethanol's toxic metabolite acetaldehyde on the gastrointestinal oligopeptide transporter, PEPT1: in vitro and in vivo studies. Alcoholism, Clinical and Experimental Research. 32: 162-70. PMID 18028524 DOI: 10.1111/J.1530-0277.2007.00551.X |
0.324 |
|
| 2008 |
Song KH, Fasano A, Eddington ND. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A. International Journal of Pharmaceutics. 351: 8-14. PMID 17954018 DOI: 10.1016/J.Ijpharm.2007.09.011 |
0.402 |
|
| 2008 |
Upreti VV, Eddington ND. Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat. Journal of Pharmaceutical Sciences. 97: 1593-605. PMID 17724664 DOI: 10.1002/jps.21045 |
0.704 |
|
| 2007 |
Othman AA, Tenero DM, Boyle DA, Eddington ND, Fossler MJ. Population pharmacokinetics of S(-)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate. The Aaps Journal. 9: E208-18. PMID 17614362 DOI: 10.1208/Aapsj0902023 |
0.324 |
|
| 2007 |
Hassan HE, Myers AL, Lee IJ, Coop A, Eddington ND. Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats. Journal of Pharmaceutical Sciences. 96: 2494-506. PMID 17593551 DOI: 10.1002/Jps.20893 |
0.642 |
|
| 2007 |
Mercer SL, Hassan HE, Cunningham CW, Eddington ND, Coop A. Opioids and efflux transporters. Part 1: P-glycoprotein substrate activity of N-substituted analogs of meperidine. Bioorganic & Medicinal Chemistry Letters. 17: 1160-2. PMID 17251015 DOI: 10.1016/J.Bmcl.2006.12.042 |
0.66 |
|
| 2007 |
Othman AA, Syed SA, Newman AH, Eddington ND. Transport, metabolism, and in vivo population pharmacokinetics of the chloro benztropine analogs, a class of compounds extensively evaluated in animal models of drug abuse. The Journal of Pharmacology and Experimental Therapeutics. 320: 344-53. PMID 17003230 DOI: 10.1124/Jpet.106.111245 |
0.347 |
|
| 2006 |
Salama NN, Eddington ND, Fasano A. Tight junction modulation and its relationship to drug delivery. Advanced Drug Delivery Reviews. 58: 15-28. PMID 16517003 DOI: 10.1016/J.Addr.2006.01.003 |
0.33 |
|
| 2006 |
Upreti VV, Khurana M, Cox DS, Eddington ND. Determination of endogenous glycosaminoglycans derived disaccharides in human plasma by HPLC: validation and application in a clinical study. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 831: 156-62. PMID 16378767 DOI: 10.1016/j.jchromb.2005.11.047 |
0.73 |
|
| 2005 |
Menon D, Karyekar CS, Fasano A, Lu R, Eddington ND. Enhancement of brain distribution of anticancer agents using DeltaG, the 12 kDa active fragment of ZOT. International Journal of Pharmaceutics. 306: 122-31. PMID 16274945 DOI: 10.1016/J.Ijpharm.2005.09.006 |
0.748 |
|
| 2005 |
Salama NN, Fasano A, Thakar M, Eddington ND. The impact of DeltaG on the oral bioavailability of low bioavailable therapeutic agents. The Journal of Pharmacology and Experimental Therapeutics. 312: 199-205. PMID 15448170 DOI: 10.1124/Jpet.104.073205 |
0.407 |
|
| 2004 |
Karyekar CS, Eddington ND, Briglia A, Gubbins PO, Dowling TC. Renal interaction between itraconazole and cimetidine. Journal of Clinical Pharmacology. 44: 919-27. PMID 15286096 DOI: 10.1177/0091270004266783 |
0.71 |
|
| 2004 |
Salama NN, Eddington ND, Payne D, Wilsonb TL, Scott KR. Multidrug resistance and anticonvulsants: new studies with some enaminones. Current Medicinal Chemistry. 11: 2093-113. PMID 15279569 DOI: 10.2174/0929867043364766 |
0.337 |
|
| 2004 |
Salama NN, Scott KR, Eddington ND. DM27, an enaminone, modifies the in vitro transport of antiviral therapeutic agents. Biopharmaceutics & Drug Disposition. 25: 227-36. PMID 15248192 DOI: 10.1002/Bdd.404 |
0.356 |
|
| 2004 |
Salama NN, Fasano A, Thakar M, Eddington ND. The effect of delta G on the transport and oral absorption of macromolecules. Journal of Pharmaceutical Sciences. 93: 1310-9. PMID 15067707 DOI: 10.1002/Jps.20052 |
0.383 |
|
| 2004 |
Salama NN, Scott KR, Eddington ND. The influence of enaminones on the transport and oral bioavailability of P-glycoprotein substrate therapeutic agents. International Journal of Pharmaceutics. 273: 135-47. PMID 15010138 DOI: 10.1016/J.Ijpharm.2003.12.020 |
0.354 |
|
| 2003 |
Khurana M, Salama NN, Scott KR, Nemieboka NN, Bauer KS, Eddington ND. Preclinical evaluation of the pharmacokinetics, brain uptake and metabolism of E121, an antiepileptic enaminone ester, in rats. Biopharmaceutics & Drug Disposition. 24: 397-407. PMID 14689468 DOI: 10.1002/Bdd.376 |
0.374 |
|
| 2003 |
Dowling TC, Briglia AE, Fink JC, Hanes DS, Light PD, Stackiewicz L, Karyekar CS, Eddington ND, Weir MR, Henrich WL. Characterization of hepatic cytochrome p4503A activity in patients with end-stage renal disease. Clinical Pharmacology and Therapeutics. 73: 427-34. PMID 12732843 DOI: 10.1016/S0009-9236(03)00056-0 |
0.682 |
|
| 2003 |
Karyekar CS, Eddington ND, Garimella TS, Gubbins PO, Dowling TC. Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model. Pharmacotherapy. 23: 436-42. PMID 12680473 DOI: 10.1592/Phco.23.4.436.32125 |
0.705 |
|
| 2003 |
Eddington ND, Cox DS, Khurana M, Salama NN, Stables JP, Harrison SJ, Negussie A, Taylor RS, Tran UQ, Moore JA, Barrow JC, Scott KR. Synthesis and anticonvulsant activity of enaminones. Part 7. Synthesis and anticonvulsant evaluation of ethyl 4-[(substituted phenyl)amino]-6-methyl-2-oxocyclohex-3-ene-1-carboxylates and their corresponding 5-methylcyclohex-2-enone derivatives. European Journal of Medicinal Chemistry. 38: 49-64. PMID 12593916 DOI: 10.1016/S0223-5234(02)00006-5 |
0.59 |
|
| 2003 |
Karyekar CS, Fasano A, Raje S, Lu R, Dowling TC, Eddington ND. Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells. Journal of Pharmaceutical Sciences. 92: 414-23. PMID 12532391 DOI: 10.1002/Jps.10310 |
0.695 |
|
| 2003 |
Salama NN, Fasano A, Lu R, Eddington ND. Effect of the biologically active fragment of zonula occludens toxin, delta G, on the intestinal paracellular transport and oral absorption of mannitol. International Journal of Pharmaceutics. 251: 113-21. PMID 12527181 DOI: 10.1016/S0378-5173(02)00589-6 |
0.351 |
|
| 2002 |
Cox DS, Raje S, Gao H, Salama NN, Eddington ND. Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin. Pharmaceutical Research. 19: 1680-8. PMID 12458674 DOI: 10.1023/A:1020709513562 |
0.631 |
|
| 2002 |
Karyekar CS, Eddington ND, Dowling TC. Effect of St. John's Wort extract on intestinal expression of cytochrome P4501A2: studies in LS180 cells. Journal of Postgraduate Medicine. 48: 97-100. PMID 12215688 |
0.673 |
|
| 2002 |
Cox DS, Scott KR, Gao H, Eddington ND. Effect of P-glycoprotein on the pharmacokinetics and tissue distribution of enaminone anticonvulsants: analysis by population and physiological approaches. The Journal of Pharmacology and Experimental Therapeutics. 302: 1096-104. PMID 12183668 DOI: 10.1124/Jpet.102.035436 |
0.637 |
|
| 2002 |
Eddington ND, Cox DS, Roberts RR, Butcher RJ, Edafiogho IO, Stables JP, Cooke N, Goodwin AM, Smith CA, Scott KR. Synthesis and anticonvulsant activity of enaminones. 4. Investigations on isoxazole derivatives. European Journal of Medicinal Chemistry. 37: 635-48. PMID 12161061 DOI: 10.1016/S0223-5234(02)01377-6 |
0.593 |
|
| 2002 |
Sirisuth N, Eddington ND. The influence of first pass metabolism on the development and validation of an IVIVC for metoprolol extended release tablets. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 53: 301-9. PMID 11976018 DOI: 10.1016/S0939-6411(01)00248-X |
0.769 |
|
| 2002 |
Sirisuth N, Augsburger LL, Eddington ND. Development and validation of a non-linear IVIVC model for a diltiazem extended release formulation. Biopharmaceutics & Drug Disposition. 23: 1-8. PMID 11891668 DOI: 10.1002/Bdd.270 |
0.764 |
|
| 2002 |
Raje S, Dowling TC, Eddington ND. Determination of the benztropine analog AHN-1055, a dopamine uptake inhibitor, in rat plasma and brain by high-performance liquid chromatography with ultraviolet absorbance detection. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 768: 305-13. PMID 11888059 DOI: 10.1016/S1570-0232(01)00614-6 |
0.35 |
|
| 2002 |
Kamimori GH, Karyekar CS, Otterstetter R, Cox DS, Balkin TJ, Belenky GL, Eddington ND. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. International Journal of Pharmaceutics. 234: 159-67. PMID 11839447 DOI: 10.1016/S0378-5173(01)00958-9 |
0.767 |
|
| 2002 |
Sirisuth N, Augsburger LL, Eddington ND. Development and validation of a non-linear IVIVC model for a diltiazem extended release formulation FDA-UMAB contract—223943401. Biopharmaceutics & Drug Disposition. 23: 1. DOI: 10.1002/Bdd.270.Abs |
0.735 |
|
| 2001 |
Cox DS, Scott KR, Gao H, Raje S, Eddington ND. Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants. Journal of Pharmaceutical Sciences. 90: 1540-52. PMID 11745712 DOI: 10.1002/jps.1104 |
0.591 |
|
| 2001 |
Cox DS, Gao H, Raje S, Scott KR, Eddington ND. Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 52: 145-50. PMID 11522479 DOI: 10.1016/S0939-6411(01)00172-2 |
0.646 |
|
| 2000 |
Cox DS, Du J, Scott KR, Gao H, Eddington ND. Determination of the enaminone DM5, an anti-epileptic agent, in mouse plasma and brain tissue by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography. B, Biomedical Sciences and Applications. 749: 191-6. PMID 11145056 DOI: 10.1016/S0378-4347(00)00411-4 |
0.629 |
|
| 2000 |
Sirisuth N, Eddington ND. Influence of stereoselective pharmacokinetics in the development and predictability of an IVIVC for the enantiomers of metoprolol tartrate. Pharmaceutical Research. 17: 1019-25. PMID 11028951 DOI: 10.1023/A:1007595725360 |
0.759 |
|
| 2000 |
Mahayni H, Rekhi GS, Uppoor RS, Marroum P, Hussain AS, Augsburger LL, Eddington ND. Evaluation of 'external' predictability of an in vitro-in vivo correlation for an extended-release formulation containing metoprolol tartrate Journal of Pharmaceutical Sciences. 89: 1354-1361. PMID 10980510 DOI: 10.1002/1520-6017(200010)89:10<1354::Aid-Jps13>3.0.Co;2-P |
0.329 |
|
| 2000 |
Kamimori GH, Sirisuth N, Greenblatt DJ, Eddington ND. The influence of the menstrual cycle on triazolam and indocyanine green pharmacokinetics. Journal of Clinical Pharmacology. 40: 739-44. PMID 10883415 DOI: 10.1177/00912700022009495 |
0.752 |
|
| 2000 |
Eddington ND, Cox DS, Roberts RR, Stables JP, Powell CB, Scott KR. Enaminones-versatile therapeutic pharmacophores. Further advances. Current Medicinal Chemistry. 7: 417-36. PMID 10702617 DOI: 10.2174/0929867003375092 |
0.598 |
|
| 1999 |
Kamimori GH, Joubert A, Otterstetter R, Santaromana M, Eddington ND. The effect of the menstrual cycle on the pharmacokinetics of caffeine in normal, healthy eumenorrheic females European Journal of Clinical Pharmacology. 55: 445-449. PMID 10492057 DOI: 10.1007/S002280050654 |
0.352 |
|
| 1999 |
Burstein AH, Cox DS, Mistry B, Eddington ND. Phenytoin pharmacokinetics following oral administration of phenytoin suspension and fosphenytoin solution to rats. Epilepsy Research. 34: 129-33. PMID 10210027 DOI: 10.1016/S0920-1211(98)00107-7 |
0.649 |
|
| 1998 |
Eddington ND, Marroum P, Uppoor R, Hussain A, Augsburger L. Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation Pharmaceutical Research. 15: 466-473. PMID 9563079 DOI: 10.1023/A:1011988601696 |
0.341 |
|
| 1997 |
Rekhi GS, Eddington ND, Fossler MJ, Schwartz P, Lesko LJ, Augsburger LL. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations Pharmaceutical Development and Technology. 2: 11-24. PMID 9552427 DOI: 10.3109/10837459709022605 |
0.344 |
|
| 1997 |
Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND. The pharmacokinetics and electroencephalogram response of remifentanil alone and in combination with esmolol in the rat Pharmaceutical Research. 14: 1817-1823. PMID 9453074 DOI: 10.1023/A:1012156502624 |
0.32 |
|
| 1996 |
Eiseman JL, Yuan ZM, Eddington ND, Sentz DL, Callery PS, Egorin MJ. Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1,19-bis(ethylamino)-5,10,15-triazanonadecane in CD2F1 mice Cancer Chemotherapy and Pharmacology. 38: 13-20. PMID 8603446 DOI: 10.1007/S002800050441 |
0.392 |
|
| 1995 |
Kamimori GH, Eddington ND, Hoyt RW, Fulco CS, Lugo S, Durkot MJ, Brunhart AE, Cymerman A. Effects of altitude (4300 m) on the pharmacokinetics of caffeine and cardio-green in humans. European Journal of Clinical Pharmacology. 48: 167-70. PMID 7589033 DOI: 10.1007/Bf00192744 |
0.357 |
|
| 1994 |
Eiseman JL, Eddington ND, Leslie J, MacAuley C, Sentz DL, Zuhowski M, Kujawa JM, Young D, Egorin MJ. Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice Cancer Chemotherapy and Pharmacology. 34: 465-471. PMID 7923556 DOI: 10.1007/Bf00685656 |
0.462 |
|
| 1990 |
Eddington ND, Young D. Biliary excretion of reduced haloperidol glucuronide Psychopharmacology. 101: 46-48. PMID 2296628 DOI: 10.1007/Bf02245788 |
0.451 |
|
| Show low-probability matches. |
